-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
412 ，
：
（411），，410，。，2028，，。
，，、。
，、，、，、。
，、。
，MI、MRI、CT、XR，。
In January of this year, according to CITIC Securities, on December 30, 2020, the Shanghai Regulatory Bureau of China Securities Regulatory Commission accepted and publicized the counseling and filing application for the initial public offering and listing of United Imaging Medical.
United Imaging Medical has signed a sci-tech innovation board listing counseling agreement, with CITIC Securities Co.
, Ltd.
and China International Capital Corporation as the sponsor and counseling agency.
This means that United Imaging Medical has officially launched the sci-tech innovation board listing process.
, Ltd.
and China International Capital Corporation as the sponsor and counseling agency.
This means that United Imaging Medical has officially launched the sci-tech innovation board listing process.
On December 31, 2020, United Imaging Medical’s official WeChat account announced that Zhang Qiang will take over Xue Min as the chairman and CEO of United Imaging Medical.
Domestic surgical robots may face difficulties
It is understood that surgical robots can overcome technical defects such as low positioning accuracy, long operation time, operator fatigue, and lack of three-dimensional medical image navigation in traditional operations, significantly improve operation accuracy and shorten operation time; on the other hand, patients have smaller wounds and bleeding Less, faster recovery.
On April 10, Tianzhihang, the first domestic surgical robot company, released its annual report.
In 2020, its revenue was about 136 million yuan, a decrease of 40.
8%.
The net profit attributable to shareholders of listed companies was about 54 million yuan, and the loss increased by 75.
95% from the previous period.
In 2020, its revenue was about 136 million yuan, a decrease of 40.
8%.
The net profit attributable to shareholders of listed companies was about 54 million yuan, and the loss increased by 75.
95% from the previous period.
Tianzhi Airlines stated in its annual report that the increase in losses was because the decline in costs was lower than the decline in operating income.
The decline in revenue was due to the impact of the epidemic, and the sales volume of the main product orthopedic surgery navigation and positioning robots declined compared with the same period last year.
At the same time, because the proportion of direct sales customers' sales is not regular, the sales volume has dropped significantly, and the average direct sales price of its products is higher than the average sales price.
At the same time, because the proportion of direct sales customers' sales is not regular, the sales volume has dropped significantly, and the average direct sales price of its products is higher than the average sales price.
Tianzhihang has lost money for three consecutive years.
Does it mean that domestic surgical robots are facing a more serious dilemma?
Does it mean that domestic surgical robots are facing a more serious dilemma?
According to the China Industry Information Network, the most widely used surgical robot in the world is the Da Vinci surgical robot produced by Intuitive Surgical.
Since the first generation of Da Vinci surgical robots passed FDA review in July 2000, Intuitive Surgical has developed and designed five generations of Da Vinci surgical robots.
Since the first generation of Da Vinci surgical robots passed FDA review in July 2000, Intuitive Surgical has developed and designed five generations of Da Vinci surgical robots.
The medical robot industry in China started late.
From the completion of the first robotic surgery in China in 1997 to the first orthopedic navigation robot with completely independent intellectual property rights in 2010, it obtained the national medical device registration license and put it into clinical use.
China's medical robot industry Speed up the process of independent innovation.
From the completion of the first robotic surgery in China in 1997 to the first orthopedic navigation robot with completely independent intellectual property rights in 2010, it obtained the national medical device registration license and put it into clinical use.
China's medical robot industry Speed up the process of independent innovation.
According to the analysis of China Industry Information Network, surgical robots are currently expensive, and surgical expenses basically need to be borne by themselves.
They have not been covered by medical insurance.
The domestic penetration and utilization rate are still low.
The installation of surgical robots in my country has increased from 27 in 2016.
87 units by 2019.
They have not been covered by medical insurance.
The domestic penetration and utilization rate are still low.
The installation of surgical robots in my country has increased from 27 in 2016.
87 units by 2019.
The development of surgical robots in my country is still facing disadvantages such as the price threshold for surgical robots to enter medical institutions, the high cost of robotic surgery, and the monopoly of intellectual property rights restricting the research and development costs of domestic surgical robots.
In the current industry predicament, whether United Imaging Medical can become a dark horse and break through the predicament seems to have become the focus of the industry.
Wearable medical equipment, the market is in a period of rapid development
For another wearable medical device market targeted by United Imaging Medical, the market space is large and it is in a stage of rapid development.
The large number of patients with chronic diseases in China means that there may be more possibilities in the market.
The large number of patients with chronic diseases in China means that there may be more possibilities in the market.
In May 2019, a report by Transparency Market Research indicated that the global wearable medical device market share is expected to exceed $29 billion by 2026, and the compound annual growth rate (CAGR) for the next seven years is expected to exceed 17%.
The report pointed out that more and more diabetic patients and health enthusiasts are paying great attention to their blood sugar, blood pressure and heart health.
The above phenomena have promoted the rapid development of wearable medical care science and technology.
The above phenomena have promoted the rapid development of wearable medical care science and technology.
For the domestic market, Flint Creations information shows that China's wearable medical equipment market reached 1.
2 billion yuan in 2015 and is expected to exceed 12.
2 billion yuan in 2020.
2 billion yuan in 2015 and is expected to exceed 12.
2 billion yuan in 2020.
The wearable medical device industry is in a period of rapid growth, although on a global scale, companies such as Epocrates, CardioNet, WellDoc, ZocDoc, and Vocera have all set successful models in the wearable medical field.
However, the richness and functionality of its products still cannot meet market demand, and the entire industry is still in a stage of rapid growth, and the future can be expected.
However, the richness and functionality of its products still cannot meet market demand, and the entire industry is still in a stage of rapid growth, and the future can be expected.
In addition, my country's wearable medical equipment has a bright future, the main reasons are:
On the one hand, my country’s aging population has caused a rapid increase in medical demand;
On the other hand, there is a serious shortage of medical resources in my country, especially in remote areas.
The gap between supply and demand brings opportunities for the development of wearable medical devices.
The gap between supply and demand brings opportunities for the development of wearable medical devices.
In the future, patients with chronic diseases such as coronary heart disease, pharmnet.
com.
cn/pharmnet/200610/hbp/" target="_blank">hypertension , and diabetes will not only receive drug treatment, but also receive overall disease management programs including remote monitoring, remote treatment program adjustment, lifestyle management, and wearable drug delivery.
com.
cn/pharmnet/200610/hbp/" target="_blank">hypertension , and diabetes will not only receive drug treatment, but also receive overall disease management programs including remote monitoring, remote treatment program adjustment, lifestyle management, and wearable drug delivery.
According to a report by Transparency Market Research, the global wearable medical device market share in 2017 was approximately 6.
8 billion U.
S.
dollars.
The top three companies in the world were Apple Inc.
of the United States, Xiaomi Inc.
of China and Fitbit Inc.
of the United States.
8 billion U.
S.
dollars.
The top three companies in the world were Apple Inc.
of the United States, Xiaomi Inc.
of China and Fitbit Inc.
of the United States.
At present, the expansion of the global medical market, government support, rising industry costs, and the continuous increase in the number of devices approved by the FDA are all driving the popularization of wearable medical devices and the continuous increase in market value.
However, the price of wearable medical equipment is usually between 150 and 1,000 US dollars, and its high price may be one of the important reasons restricting its popularization and application in developing countries.
Pharm.
com.
cn on April 12th.
High-end equipment is produced and sold locally, with an estimated annual revenue of tens of billions
com.
cn on April 12th.
High-end equipment is produced and sold locally, with an estimated annual revenue of tens of billions
United Imaging Medical: Focus on these two fields
Today (April 11), according to the Yangtze River Daily, on April 10, United Imaging Medical Wuhan Headquarters was officially opened.
After the base is put into use, by 2028, localized production and sales of high-end medical equipment will be realized, with an estimated annual income of 10 billion yuan.
After the base is put into use, by 2028, localized production and sales of high-end medical equipment will be realized, with an estimated annual income of 10 billion yuan.
According to reports, United Imaging Medical will focus on building a high-end medical equipment R&D and intelligent manufacturing center of United Imaging in Wuhan, and independently develop and produce advanced medical equipment such as surgical robots and medical wearable equipment.
According to United Imaging Medical, it is currently conducting strategic cooperation with the team of Academician of the Chinese Academy of Sciences, Professor Ding Han, Dean of the School of Mechanical Science and Engineering of Huazhong University of Science and Technology, Academician of the Chinese Academy of Sciences, and Professor Chen Xiaoping of Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology .
Inclusive robots and surgical robots are used in the medical field.
Inclusive robots and surgical robots are used in the medical field.
United Imaging Medical has signed a comprehensive strategic cooperation agreement with Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology to carry out research and development of intelligent surgical robots and medical wearable devices.
It is understood that the products of United Imaging Medical include MI, MRI, CT, XR and other medical imaging diagnostic products, and radiotherapy equipment products.
In January of this year, according to CITIC Securities, on December 30, 2020, the Shanghai Regulatory Bureau of China Securities Regulatory Commission accepted and publicized the counseling and filing application for the initial public offering and listing of United Imaging Medical.
United Imaging Medical has signed a sci-tech innovation board listing counseling agreement, with CITIC Securities Co.
, Ltd.
and China International Capital Corporation as the sponsor and counseling agency.
This means that United Imaging Medical has officially launched the sci-tech innovation board listing process.
, Ltd.
and China International Capital Corporation as the sponsor and counseling agency.
This means that United Imaging Medical has officially launched the sci-tech innovation board listing process.
On December 31, 2020, United Imaging Medical’s official WeChat account announced that Zhang Qiang will take over Xue Min as the chairman and CEO of United Imaging Medical.
Domestic surgical robots may face difficulties
It is understood that surgical robots can overcome technical defects such as low positioning accuracy, long operation time, operator fatigue, and lack of three-dimensional medical image navigation in traditional operations, significantly improve operation accuracy and shorten operation time; on the other hand, patients have smaller wounds and bleeding Less, faster recovery.
On April 10, Tianzhihang, the first domestic surgical robot company, released its annual report.
In 2020, its revenue was about 136 million yuan, a decrease of 40.
8%.
The net profit attributable to shareholders of listed companies was about 54 million yuan, and the loss increased by 75.
95% from the previous period.
In 2020, its revenue was about 136 million yuan, a decrease of 40.
8%.
The net profit attributable to shareholders of listed companies was about 54 million yuan, and the loss increased by 75.
95% from the previous period.
Tianzhi Airlines stated in its annual report that the increase in losses was because the decline in costs was lower than the decline in operating income.
The decline in revenue was due to the impact of the epidemic, and the sales volume of the main product orthopedic surgery navigation and positioning robots declined compared with the same period last year.
At the same time, because the proportion of direct sales customers' sales is not regular, the sales volume has dropped significantly, and the average direct sales price of its products is higher than the average sales price.
At the same time, because the proportion of direct sales customers' sales is not regular, the sales volume has dropped significantly, and the average direct sales price of its products is higher than the average sales price.
Tianzhihang has lost money for three consecutive years.
Does it mean that domestic surgical robots are facing a more serious dilemma?
Does it mean that domestic surgical robots are facing a more serious dilemma?
According to the China Industry Information Network, the most widely used surgical robot in the world is the Da Vinci surgical robot produced by Intuitive Surgical.
Since the first generation of Da Vinci surgical robots passed FDA review in July 2000, Intuitive Surgical has developed and designed five generations of Da Vinci surgical robots.
Since the first generation of Da Vinci surgical robots passed FDA review in July 2000, Intuitive Surgical has developed and designed five generations of Da Vinci surgical robots.
The medical robot industry in China started late.
From the completion of the first robotic surgery in China in 1997 to the first orthopedic navigation robot with completely independent intellectual property rights in 2010, it obtained the national medical device registration license and put it into clinical use.
China's medical robot industry Speed up the process of independent innovation.
From the completion of the first robotic surgery in China in 1997 to the first orthopedic navigation robot with completely independent intellectual property rights in 2010, it obtained the national medical device registration license and put it into clinical use.
China's medical robot industry Speed up the process of independent innovation.
According to the analysis of China Industry Information Network, surgical robots are currently expensive, and surgical expenses basically need to be borne by themselves.
They have not been covered by medical insurance.
The domestic penetration and utilization rate are still low.
The installation of surgical robots in my country has increased from 27 in 2016.
87 units by 2019.
They have not been covered by medical insurance.
The domestic penetration and utilization rate are still low.
The installation of surgical robots in my country has increased from 27 in 2016.
87 units by 2019.
The development of surgical robots in my country is still facing disadvantages such as the price threshold for surgical robots to enter medical institutions, the high cost of robotic surgery, and the monopoly of intellectual property rights restricting the research and development costs of domestic surgical robots.
In the current industry predicament, whether United Imaging Medical can become a dark horse and break through the predicament seems to have become the focus of the industry.
Wearable medical equipment, the market is in a period of rapid development
For another wearable medical device market targeted by United Imaging Medical, the market space is large and it is in a stage of rapid development.
The large number of patients with chronic diseases in China means that there may be more possibilities in the market.
The large number of patients with chronic diseases in China means that there may be more possibilities in the market.
In May 2019, a report by Transparency Market Research indicated that the global wearable medical device market share is expected to exceed $29 billion by 2026, and the compound annual growth rate (CAGR) for the next seven years is expected to exceed 17%.
The report pointed out that more and more diabetic patients and health enthusiasts are paying great attention to their blood sugar, blood pressure and heart health.
The above phenomena have promoted the rapid development of wearable medical care science and technology.
The above phenomena have promoted the rapid development of wearable medical care science and technology.
For the domestic market, Flint Creations information shows that China's wearable medical equipment market reached 1.
2 billion yuan in 2015 and is expected to exceed 12.
2 billion yuan in 2020.
2 billion yuan in 2015 and is expected to exceed 12.
2 billion yuan in 2020.
The wearable medical device industry is in a period of rapid growth, although on a global scale, companies such as Epocrates, CardioNet, WellDoc, ZocDoc, and Vocera have all set successful models in the wearable medical field.
However, the richness and functionality of its products still cannot meet market demand, and the entire industry is still in a stage of rapid growth, and the future can be expected.
However, the richness and functionality of its products still cannot meet market demand, and the entire industry is still in a stage of rapid growth, and the future can be expected.
In addition, my country's wearable medical equipment has a bright future, the main reasons are:
On the one hand, my country’s aging population has caused a rapid increase in medical demand;
On the other hand, there is a serious shortage of medical resources in my country, especially in remote areas.
The gap between supply and demand brings opportunities for the development of wearable medical devices.
The gap between supply and demand brings opportunities for the development of wearable medical devices.
In the future, patients with chronic diseases such as coronary heart disease, pharmnet.
com.
cn/pharmnet/200610/hbp/" target="_blank">hypertension , and diabetes will not only receive drug treatment, but also receive overall disease management programs including remote monitoring, remote treatment program adjustment, lifestyle management, and wearable drug delivery.
com.
cn/pharmnet/200610/hbp/" target="_blank">hypertension , and diabetes will not only receive drug treatment, but also receive overall disease management programs including remote monitoring, remote treatment program adjustment, lifestyle management, and wearable drug delivery.
According to a report by Transparency Market Research, the global wearable medical device market share in 2017 was approximately 6.
8 billion U.
S.
dollars.
The top three companies in the world were Apple Inc.
of the United States, Xiaomi Inc.
of China and Fitbit Inc.
of the United States.
8 billion U.
S.
dollars.
The top three companies in the world were Apple Inc.
of the United States, Xiaomi Inc.
of China and Fitbit Inc.
of the United States.
At present, the expansion of the global medical market, government support, rising industry costs, and the continuous increase in the number of devices approved by the FDA are all driving the popularization of wearable medical devices and the continuous increase in market value.
However, the price of wearable medical equipment is usually between 150 and 1,000 US dollars, and its high price may be one of the important reasons restricting its popularization and application in developing countries.
Pharm.
com.
cn on April 12th.
High-end equipment is produced and sold locally, with an estimated annual revenue of tens of billions
com.
cn on April 12th.
High-end equipment is produced and sold locally, with an estimated annual revenue of tens of billions
United Imaging Medical: Focus on these two fields
United Imaging Medical: Focus on these two fields Today (April 11), according to the Yangtze River Daily, on April 10, United Imaging Medical Wuhan Headquarters was officially opened.
After the base is put into use, by 2028, localized production and sales of high-end medical equipment will be realized, with an estimated annual income of 10 billion yuan.
After the base is put into use, by 2028, localized production and sales of high-end medical equipment will be realized, with an estimated annual income of 10 billion yuan.
According to reports, United Imaging Medical will focus on building a high-end medical equipment R&D and intelligent manufacturing center of United Imaging in Wuhan, and independently develop and produce advanced medical equipment such as surgical robots and medical wearable equipment.
According to United Imaging Medical, it is currently conducting strategic cooperation with the team of Academician of the Chinese Academy of Sciences, Professor Ding Han, Dean of the School of Mechanical Science and Engineering of Huazhong University of Science and Technology, Academician of the Chinese Academy of Sciences, and Professor Chen Xiaoping of Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology .
Inclusive robots and surgical robots are used in the medical field.
Hospital hospital hospitalInclusive robots and surgical robots are used in the medical field.
United Imaging Medical has signed a comprehensive strategic cooperation agreement with Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology to carry out research and development of intelligent surgical robots and medical wearable devices.
It is understood that the products of United Imaging Medical include MI, MRI, CT, XR and other medical imaging diagnostic products, and radiotherapy equipment products.
In January of this year, according to CITIC Securities, on December 30, 2020, the Shanghai Regulatory Bureau of China Securities Regulatory Commission accepted and publicized the counseling and filing application for the initial public offering and listing of United Imaging Medical.
United Imaging Medical has signed a sci-tech innovation board listing counseling agreement, with CITIC Securities Co.
, Ltd.
and China International Capital Corporation as the sponsor and counseling agency.
This means that United Imaging Medical has officially launched the sci-tech innovation board listing process.
, Ltd.
and China International Capital Corporation as the sponsor and counseling agency.
This means that United Imaging Medical has officially launched the sci-tech innovation board listing process.
On December 31, 2020, United Imaging Medical’s official WeChat account announced that Zhang Qiang will take over Xue Min as the chairman and CEO of United Imaging Medical.
Domestic surgical robots may face difficulties
Domestic surgical robots may face difficulties It is understood that surgical robots can overcome technical defects such as low positioning accuracy, long operation time, operator fatigue, and lack of three-dimensional medical image navigation in traditional operations, significantly improve operation accuracy and shorten operation time; on the other hand, patients have smaller wounds and bleeding Less, faster recovery.
On April 10, Tianzhihang, the first domestic surgical robot company, released its annual report.
In 2020, its revenue was about 136 million yuan, a decrease of 40.
8%.
The net profit attributable to shareholders of listed companies was about 54 million yuan, and the loss increased by 75.
95% from the previous period.
In 2020, its revenue was about 136 million yuan, a decrease of 40.
8%.
The net profit attributable to shareholders of listed companies was about 54 million yuan, and the loss increased by 75.
95% from the previous period.
Tianzhi Airlines stated in its annual report that the increase in losses was because the decline in costs was lower than the decline in operating income.
The decline in revenue was due to the impact of the epidemic, and the sales volume of the main product orthopedic surgery navigation and positioning robots declined compared with the same period last year.
At the same time, because the proportion of direct sales customers' sales is not regular, the sales volume has dropped significantly, and the average direct sales price of its products is higher than the average sales price.
At the same time, because the proportion of direct sales customers' sales is not regular, the sales volume has dropped significantly, and the average direct sales price of its products is higher than the average sales price.
Tianzhihang has lost money for three consecutive years.
Does it mean that domestic surgical robots are facing a more serious dilemma?
Does it mean that domestic surgical robots are facing a more serious dilemma?
According to the China Industry Information Network, the most widely used surgical robot in the world is the Da Vinci surgical robot produced by Intuitive Surgical.
Since the first generation of Da Vinci surgical robots passed FDA review in July 2000, Intuitive Surgical has developed and designed five generations of Da Vinci surgical robots.
Since the first generation of Da Vinci surgical robots passed FDA review in July 2000, Intuitive Surgical has developed and designed five generations of Da Vinci surgical robots.
The medical robot industry in China started late.
From the completion of the first robotic surgery in China in 1997 to the first orthopedic navigation robot with completely independent intellectual property rights in 2010, it obtained the national medical device registration license and put it into clinical use.
China's medical robot industry Speed up the process of independent innovation.
Medical equipment medical equipment medical equipmentFrom the completion of the first robotic surgery in China in 1997 to the first orthopedic navigation robot with completely independent intellectual property rights in 2010, it obtained the national medical device registration license and put it into clinical use.
China's medical robot industry Speed up the process of independent innovation.
According to the analysis of China Industry Information Network, surgical robots are currently expensive, and surgical expenses basically need to be borne by themselves.
They have not been covered by medical insurance.
The domestic penetration and utilization rate are still low.
The installation of surgical robots in my country has increased from 27 in 2016.
87 units by 2019.
They have not been covered by medical insurance.
The domestic penetration and utilization rate are still low.
The installation of surgical robots in my country has increased from 27 in 2016.
87 units by 2019.
The development of surgical robots in my country is still facing disadvantages such as the price threshold for surgical robots to enter medical institutions, the high cost of robotic surgery, and the monopoly of intellectual property rights restricting the research and development costs of domestic surgical robots.
In the current industry predicament, whether United Imaging Medical can become a dark horse and break through the predicament seems to have become the focus of the industry.
Wearable medical equipment, the market is in a period of rapid development
For another wearable medical device market targeted by United Imaging Medical, the market space is large and it is in a stage of rapid development.
The large number of patients with chronic diseases in China means that there may be more possibilities in the market.
The large number of patients with chronic diseases in China means that there may be more possibilities in the market.
In May 2019, a report by Transparency Market Research indicated that the global wearable medical device market share is expected to exceed $29 billion by 2026, and the compound annual growth rate (CAGR) for the next seven years is expected to exceed 17%.
The report pointed out that more and more diabetic patients and health enthusiasts are paying great attention to their blood sugar, blood pressure and heart health.
The above phenomena have promoted the rapid development of wearable medical care science and technology.
Health Health Health Care Health CareThe above phenomena have promoted the rapid development of wearable medical care science and technology.
For the domestic market, Flint Creations information shows that China's wearable medical equipment market reached 1.
2 billion yuan in 2015 and is expected to exceed 12.
2 billion yuan in 2020.
2 billion yuan in 2015 and is expected to exceed 12.
2 billion yuan in 2020.
The wearable medical device industry is in a period of rapid growth, although on a global scale, companies such as Epocrates, CardioNet, WellDoc, ZocDoc, and Vocera have all set successful models in the wearable medical field.
However, the richness and functionality of its products still cannot meet market demand, and the entire industry is still in a stage of rapid growth, and the future can be expected.
However, the richness and functionality of its products still cannot meet market demand, and the entire industry is still in a stage of rapid growth, and the future can be expected.
In addition, my country's wearable medical equipment has a bright future, the main reasons are:
On the one hand, my country’s aging population has caused a rapid increase in medical demand;
On the other hand, there is a serious shortage of medical resources in my country, especially in remote areas.
The gap between supply and demand brings opportunities for the development of wearable medical devices.
The gap between supply and demand brings opportunities for the development of wearable medical devices.
In the future, patients with chronic diseases such as coronary heart disease, pharmnet.
com.
cn/pharmnet/200610/hbp/" target="_blank">hypertension , and diabetes will not only receive drug treatment, but also receive overall disease management programs including remote monitoring, remote treatment program adjustment, lifestyle management, and wearable drug delivery.
pharmnet. com.
cn/pharmnet/200610/hbp/" target="_blank">hypertension , and diabetes will not only receive drug treatment, but also receive overall disease management programs including remote monitoring, remote treatment program adjustment, lifestyle management, and wearable drug delivery.
com.
cn/pharmnet/200610/hbp/" target="_blank">Hypertensionpharmnet.
com.
cn/pharmnet/200610/hbp/" target="_blank"> hypertension hypertension
According to a report by Transparency Market Research, the global wearable medical device market share in 2017 was approximately 6.
8 billion U.
S.
dollars.
The top three companies in the world were Apple Inc.
of the United States, Xiaomi Inc.
of China and Fitbit Inc.
of the United States.
8 billion U.
S.
dollars.
The top three companies in the world were Apple Inc.
of the United States, Xiaomi Inc.
of China and Fitbit Inc.
of the United States.
At present, the expansion of the global medical market, government support, rising industry costs, and the continuous increase in the number of devices approved by the FDA are all driving the popularization of wearable medical devices and the continuous increase in market value.
However, the price of wearable medical equipment is usually between 150 and 1,000 US dollars, and its high price may be one of the important reasons restricting its popularization and application in developing countries.
